Strobel J, Muller H, Ludolph A, Beer A, Sollmann N, Kassubek J
Cells. 2023; 12(24).
PMID: 38132096
PMC: 10742083.
DOI: 10.3390/cells12242776.
Nikolaus S, Wittsack H, Antke C, Beu M, Hautzel H, Decheva C
Front Neurosci. 2021; 15:682398.
PMID: 34456668
PMC: 8387951.
DOI: 10.3389/fnins.2021.682398.
Wang G, Rahmim A, Gunn R
IEEE Trans Radiat Plasma Med Sci. 2021; 4(6):663-675.
PMID: 33763624
PMC: 7983029.
DOI: 10.1109/trpms.2020.3025086.
Nikolaus S, Wittsack H, Wickrath F, Muller-Lutz A, Hautzel H, Beu M
Sci Rep. 2019; 9(1):16128.
PMID: 31695055
PMC: 6834679.
DOI: 10.1038/s41598-019-52185-7.
Sollini M, Bandera F, Kirienko M
Eur J Nucl Med Mol Imaging. 2019; 46(13):2737-2745.
PMID: 31690962
DOI: 10.1007/s00259-019-04531-0.
Serotonin Transporter Binding in the Human Brain After Pharmacological Challenge Measured Using PET and PET/MR.
Silberbauer L, Gryglewski G, Berroteran-Infante N, Rischka L, Vanicek T, Pichler V
Front Mol Neurosci. 2019; 12:172.
PMID: 31354428
PMC: 6639732.
DOI: 10.3389/fnmol.2019.00172.
Investigation of the influence of sampling schemes on quantitative dynamic fluorescence imaging.
Dai Y, Chen X, Yin J, Wang G, Wang B, Zhan Y
Biomed Opt Express. 2018; 9(4):1859-1870.
PMID: 29675325
PMC: 5905930.
DOI: 10.1364/BOE.9.001859.
GABAergic Control of Nigrostriatal and Mesolimbic Dopamine in the Rat Brain.
Nikolaus S, Wittsack H, Beu M, Antke C, de Souza Silva M, Wickrath F
Front Behav Neurosci. 2018; 12:38.
PMID: 29593508
PMC: 5862131.
DOI: 10.3389/fnbeh.2018.00038.
Spectral Analysis of Dynamic PET Studies: A Review of 20 Years of Method Developments and Applications.
Veronese M, Rizzo G, Bertoldo A, Turkheimer F
Comput Math Methods Med. 2017; 2016:7187541.
PMID: 28050197
PMC: 5165231.
DOI: 10.1155/2016/7187541.
Brain (18)F-FDG, (18)F-Florbetaben PET/CT, (123)I-FP-CIT SPECT and Cardiac (123)I-MIBG Imaging for Diagnosis of a "Cerebral Type" of Lewy Body Disease.
Van Der Gucht A, Cleret de Langavant L, Belissant O, Rabu C, Cottereau A, Evangelista E
Nucl Med Mol Imaging. 2016; 50(3):258-60.
PMID: 27540431
PMC: 4977251.
DOI: 10.1007/s13139-016-0394-0.
In vivo quantifying molecular specificity of Cy5.5-labeled cyclic 9-mer peptide probe with dynamic fluorescence imaging.
Dai Y, Yin J, Huang Y, Chen X, Wang G, Liu Y
Biomed Opt Express. 2016; 7(4):1149-59.
PMID: 27446643
PMC: 4929628.
DOI: 10.1364/BOE.7.001149.
Dynamic Imaging of Individual Remyelination Profiles in Multiple Sclerosis.
Bodini B, Veronese M, Garcia-Lorenzo D, Battaglini M, Poirion E, Chardain A
Ann Neurol. 2016; 79(5):726-738.
PMID: 26891452
PMC: 5006855.
DOI: 10.1002/ana.24620.
Disproportionate Reduction of Serotonin Transporter May Predict the Response and Adherence to Antidepressants in Patients with Major Depressive Disorder: A Positron Emission Tomography Study with 4-[18F]-ADAM.
Yeh Y, Ho P, Kuo S, Chen C, Liang C, Yen C
Int J Neuropsychopharmacol. 2015; 18(7):pyu120.
PMID: 25568284
PMC: 4540099.
DOI: 10.1093/ijnp/pyu120.
Bayesian Analysis of a One Compartment Kinetic Model Used in Medical Imaging.
Malave P, Sitek A
J Appl Stat. 2014; 42(1):98-113.
PMID: 25408561
PMC: 4232966.
DOI: 10.1080/02664763.2014.934666.
Recent advances in parametric neuroreceptor mapping with dynamic PET: basic concepts and graphical analyses.
Seo S, Kim S, Lee D, Lee J
Neurosci Bull. 2014; 30(5):733-54.
PMID: 25260795
PMC: 5562590.
DOI: 10.1007/s12264-014-1465-9.
Exploring the impact of BDNF Val66Met genotype on serotonin transporter and serotonin-1A receptor binding.
Kraus C, Baldinger P, Rami-Mark C, Gryglewski G, Gryglewsky G, Kranz G
PLoS One. 2014; 9(9):e106810.
PMID: 25188405
PMC: 4154779.
DOI: 10.1371/journal.pone.0106810.
Modeling of PET data in CNS drug discovery and development.
Varnas K, Varrone A, Farde L
J Pharmacokinet Pharmacodyn. 2013; 40(3):267-79.
PMID: 23660778
DOI: 10.1007/s10928-013-9320-6.
PET imaging for receptor occupancy: meditations on calculation and simplification.
Zhang Y, Fox G
J Biomed Res. 2013; 26(2):69-76.
PMID: 23554733
PMC: 3597321.
DOI: 10.1016/S1674-8301(12)60014-1.
Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism.
Vauquelin G, Bostoen S, Vanderheyden P, Seeman P
Naunyn Schmiedebergs Arch Pharmacol. 2012; 385(4):337-72.
PMID: 22331262
DOI: 10.1007/s00210-012-0734-2.
SPECT imaging evaluation in movement disorders: far beyond visual assessment.
Badiavas K, Molyvda E, Iakovou I, Tsolaki M, Psarrakos K, Karatzas N
Eur J Nucl Med Mol Imaging. 2010; 38(4):764-73.
PMID: 21125269
DOI: 10.1007/s00259-010-1664-1.